The search for a COVID-19 vaccine takes a big step.
"I'm very anxious about it. I hope that they get really good results," said Dawn Baker. Baker is the first person to receive a COVID-19 vaccine under development by bio-tech company Moderna.
It's part of the first phase three trial that will vaccinate 30,000 people across the country. Pennsylvania is not part of the trial.
Once the trial is complete, researchers hope to get approval from the FDA, possibly having the vaccine in use by early 2021.
But for some, this fast-track approach to a COVID vaccine is not sitting well. On WFMZ's Facebook page, there are plenty of people saying they wouldn't get the vaccine.
"I do understand why it would also be some cause for anxiety," said Dr. Jeffrey Jahre with St. Luke's University Health Network.
Jahre says the development of COVID vaccines is happening in record time.
"Because of new technology we have the ability at this point in time to bring these things into being in a much more rapid fashion," said Jahre.
Dr. Luther Rhodes with Lehigh Valley Health Network says with any vaccine there are risks and rewards, but that their timing should not be a concern. He said safety is priority one within the scientific and research community.
"Over hundreds of years vaccines have been introduced, have proven increasingly that they can be effective they can totally eliminate conditions, so I am hopeful," said Rhodes.
Rhodes says several more vaccines are about to enter into phase three trials across the US. And in the end, several might emerge, although he believes no one will be required to take them.